BriaCell Therapeutics Corp (BCTX)
0.6079
+0.01
(+1.38%)
USD |
NASDAQ |
Nov 14, 12:33
BriaCell Therapeutics Total Assets (Quarterly): 5.872M for July 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
July 31, 2024 | 5.872M |
April 30, 2024 | 6.203M |
January 31, 2024 | 12.23M |
October 31, 2023 | 18.62M |
July 31, 2023 | 27.16M |
April 30, 2023 | 29.72M |
January 31, 2023 | 34.16M |
October 31, 2022 | 38.45M |
July 31, 2022 | 42.58M |
April 30, 2022 | 46.46M |
January 31, 2022 | 48.55M |
October 31, 2021 | 56.16M |
July 31, 2021 | 58.04M |
April 30, 2021 | 21.05M |
January 31, 2021 | 0.4575M |
October 31, 2020 | 0.4529M |
July 31, 2020 | 0.5223M |
April 30, 2020 | 0.4398M |
January 31, 2020 | 0.4781M |
October 31, 2019 | 0.4764M |
July 31, 2019 | 0.4447M |
April 30, 2019 | 1.199M |
January 31, 2019 | 0.9377M |
October 31, 2018 | 1.406M |
July 31, 2018 | 2.285M |
Date | Value |
---|---|
April 30, 2018 | 3.709M |
January 31, 2018 | 0.7969M |
October 31, 2017 | 1.317M |
July 31, 2017 | 1.636M |
April 30, 2017 | 1.591M |
January 31, 2017 | 1.369M |
October 31, 2016 | 1.646M |
July 31, 2016 | 0.8357M |
April 30, 2016 | 1.213M |
January 31, 2016 | 0.6029M |
October 31, 2015 | 0.9785M |
July 31, 2015 | 1.276M |
April 30, 2015 | 1.668M |
January 31, 2015 | 1.768M |
October 31, 2014 | 2.695M |
July 31, 2014 | 0.0239M |
April 30, 2014 | 8.162M |
January 31, 2014 | 8.551M |
October 31, 2013 | 9.175M |
July 31, 2013 | 9.408M |
April 30, 2013 | 9.656M |
January 31, 2013 | 9.865M |
October 31, 2012 | 10.07M |
July 31, 2012 | 10.32M |
April 30, 2012 | 10.84M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
0.4398M
Minimum
Apr 2020
58.04M
Maximum
Jul 2021
23.56M
Average
21.05M
Median
Apr 2021
Total Assets (Quarterly) Benchmarks
CeCors Inc | -- |
Venus Concept Inc | 79.75M |
Aurinia Pharmaceuticals Inc | 549.36M |
Edesa Biotech Inc | 5.228M |
Lexaria Bioscience Corp | 10.02M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 8.557M |
Shareholders Equity (Quarterly) | -2.382M |